A citation-based method for searching scientific literature

Susanne B Haga, Rachel Mills. Pharmacogenomics 2016
Times Cited: 5







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
Susanne B Haga, Ariel Kantor. Health Aff (Millwood) 2018
15
60

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin. Genet. 2012
133
60

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin. Pharmacol. Ther. 2014
132
40

Development and use of active clinical decision support for preemptive pharmacogenomics.
Gillian C Bell, Kristine R Crews, Mark R Wilkinson, Cyrine E Haidar, J Kevin Hicks, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Shane J Cross, Scott C Howard,[...]. J Am Med Inform Assoc 2014
109
40

Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
113
40

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
James M Hoffman, Cyrine E Haidar, Mark R Wilkinson, Kristine R Crews, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Ching-Hon Pui, Ulrike M Reiss, Aditya H Gaur,[...]. Am J Med Genet C Semin Med Genet 2014
123
40

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
268
40

Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
Henry M Dunnenberger, Matthew Biszewski, Gillian C Bell, Annette Sereika, Holley May, Samuel G Johnson, Peter J Hulick, Janardan Khandekar. Am J Health Syst Pharm 2016
30
40

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin. Pharmacol. Ther. 2017
57
40

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab,[...]. Curr. Drug Metab. 2014
163
40

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin. Pharmacol. Ther. 2011
480
40

The IGNITE network: a model for genomic medicine implementation and research.
Kristin Wiisanen Weitzel, Madeline Alexander, Barbara A Bernhardt, Neil Calman, David J Carey, Larisa H Cavallari, Julie R Field, Diane Hauser, Heather A Junkins, Phillip A Levin,[...]. BMC Med Genomics 2016
98
40

Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services.
J Kevin Hicks, David Stowe, Marc A Willner, Maya Wai, Thomas Daly, Steven M Gordon, Bret A Lashner, Sumit Parikh, Robert White, Kathryn Teng,[...]. Pharmacotherapy 2016
43
40

Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
L V Kalman, Jag Agúndez, M Lindqvist Appell, J L Black, G C Bell, S Boukouvala, C Bruckner, E Bruford, K Caudle, S A Coulthard,[...]. Clin. Pharmacol. Ther. 2016
65
40

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J. 2012
79
40

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin. Pharmacol. Ther. 2017
124
40

Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.
Nicholas J Keeling, Meagen M Rosenthal, Donna West-Strum, Amit S Patel, Cyrine E Haidar, James M Hoffman. Genet. Med. 2019
17
40


Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
James M Hoffman, Henry M Dunnenberger, J Kevin Hicks, Kelly E Caudle, Michelle Whirl Carrillo, Robert R Freimuth, Marc S Williams, Teri E Klein, Josh F Peterson. J Am Med Inform Assoc 2016
36
40

Collaborative Counseling Considerations for Pharmacogenomic Tests.
Heather A Zierhut, Colleen A Campbell, Allison G Mitchell, Amy A Lemke, Rachel Mills, Jeffrey R Bishop. Pharmacotherapy 2017
10
40

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin. Pharmacol. Ther. 2014
302
40

Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
Marie-Pier Frigon, Marie-Ève Blackburn, Camélia Dubois-Bouchard, Ann-Lorie Gagnon, Suzie Tardif, Karine Tremblay. Pharmacogenomics 2019
5
40


Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
Philip E Empey, James M Stevenson, Sony Tuteja, Kristin W Weitzel, Dominick J Angiolillo, Amber L Beitelshees, James C Coons, Julio D Duarte, Francesco Franchi, Linda J B Jeng,[...]. Clin. Pharmacol. Ther. 2018
41
40

Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
Emily J Cicali, Kristin Wiisanen Weitzel, Amanda R Elsey, Frank A Orlando, Michelle Vinson, Scott Mosley, D Max Smith, Richard Davis, Lori Drum, David Estores,[...]. Genet. Med. 2019
9
40

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin. Pharmacol. Ther. 2012
659
40

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin. Pharmacol. Ther. 2015
275
40

Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Kelly E Caudle, Roseann S Gammal, Michelle Whirl-Carrillo, James M Hoffman, Mary V Relling, Teri E Klein. Am J Health Syst Pharm 2016
30
40

Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.
Jeffrey R Botkin, John W Belmont, Jonathan S Berg, Benjamin E Berkman, Yvonne Bombard, Ingrid A Holm, Howard P Levy, Kelly E Ormond, Howard M Saal, Nancy B Spinner,[...]. Am. J. Hum. Genet. 2015
174
40

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz.  2018
31
40

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu. Rev. Pharmacol. Toxicol. 2015
205
40

Deciphering next-generation pharmacogenomics: an information technology perspective.
George Potamias, Kleanthi Lakiotaki, Theodora Katsila, Ming Ta Michael Lee, Stavros Topouzis, David N Cooper, George P Patrinos. Open Biol 2014
21
20

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
77
20

Implementation of a pharmacogenomics service in a community pharmacy.
Stefanie P Ferreri, Angelo J Greco, Natasha M Michaels, Shanna K O'Connor, Rebecca W Chater, Anthony J Viera, Hawazin Faruki, Howard L McLeod, Mary W Roederer. J Am Pharm Assoc (2003) 2014
36
20

The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
P H O'Donnell, A Bush, J Spitz, K Danahey, D Saner, S Das, N J Cox, M J Ratain. Clin. Pharmacol. Ther. 2012
101
20

A regulatory protocol for pharmacogenomics services.
L A Bristol. Pharmacogenomics J. 2002
3
33


Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML.
Neil T Mason, Gillian C Bell, Rod E Quilitz, John N Greene, Howard L McLeod. J. Antimicrob. Chemother. 2015
9
20

Insurance coverage policies for personalized medicine.
Andrew Hresko, Susanne B Haga.  2012
50
20

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol. Psychiatry 2004
413
20

Pharmacogenomics, ancestry and clinical decision making for global populations.
E Ramos, A Doumatey, A G Elkahloun, D Shriner, H Huang, G Chen, J Zhou, H McLeod, A Adeyemo, C N Rotimi. Pharmacogenomics J. 2014
48
20

Standardization and quality management in next-generation sequencing.
Christoph Endrullat, Jörn Glökler, Philipp Franke, Marcus Frohme.  2016
59
20

Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.
Magnus Ingelman-Sundberg, Cristina Rodriguez-Antona. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 2005
61
20

Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping.
Jean E Abraham, Mel J Maranian, Inmaculada Spiteri, Roslin Russell, Susan Ingle, Craig Luccarini, Helena M Earl, Paul P D Pharoah, Alison M Dunning, Carlos Caldas. BMC Med Genomics 2012
57
20

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
L J Rasmussen-Torvik, S C Stallings, A S Gordon, B Almoguera, M A Basford, S J Bielinski, A Brautbar, M H Brilliant, D S Carrell, J J Connolly,[...]. Clin. Pharmacol. Ther. 2014
126
20

Complexities of CYP2D6 gene analysis and interpretation.
Andrea Gaedigk. Int Rev Psychiatry 2013
99
20

The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency.
Wendy S Rubinstein, Donna R Maglott, Jennifer M Lee, Brandi L Kattman, Adriana J Malheiro, Michael Ovetsky, Vichet Hem, Viatcheslav Gorelenkov, Guangfeng Song, Craig Wallin,[...]. Nucleic Acids Res. 2013
65
20

Feasibility of implementing a comprehensive warfarin pharmacogenetics service.
Edith A Nutescu, Katarzyna Drozda, Adam P Bress, William L Galanter, James Stevenson, Thomas D Stamos, Ankit A Desai, Julio D Duarte, Victor Gordeuk, David Peace,[...]. Pharmacotherapy 2013
44
20

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.
M J Arwood, S Chumnumwat, L H Cavallari, E A Nutescu, J D Duarte. Clin Transl Sci 2016
31
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.